CompletedNot Applicable

Peer Education Based on Integrated Change Model on Nursing Students' STI-Related Behaviors

Turkey (Türkiye)36 participantsStarted 2025-09-01

Plain-language summary

This study aims to compare the effectiveness of two peer education models on nursing students' behaviors, attitudes, and knowledge regarding sexually transmitted infections (STIs). First-year nursing students will be randomly assigned to one of two groups. The intervention group will receive a peer education program developed based on the Integrated Change Model (ICM), while the control group will receive standard peer education. Both programs will be delivered by a fourth-year nursing student (peer educator) in four weekly sessions of 30 minutes each. The ICM integrates key principles from major behavior change theories including the Theory of Planned Behavior, Social Cognitive Theory, the Transtheoretical Model, and the Health Belief Model. By combining peer education with this theoretical framework, the study seeks to promote lasting positive changes in STI-related protective behaviors among nursing students. Data will be collected using validated scales measuring STI-related behaviors, attitudes, and knowledge before and after the intervention. The study will contribute to the development of more effective STI prevention programs in university settings.

Who can participate

Age range

18 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * First-year nursing student enrolled at Sakarya University Faculty of Health Sciences in the 2025-2026 academic year * No prior formal education on sexually transmitted infections within the undergraduate curriculum * Voluntary written informed consent to participate Exclusion Criteria: * Participation in another sexual health education program during the study period * Absence from more than one of the four education sessions

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

STI-Related Protective Behaviors

Timeframe: Baseline (Week 0) and immediately after the intervention (Week 4)

Trial details

NCT IDNCT07666152

SponsorSakarya University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2026-04-01

View on ClinicalTrials.gov More Sexually Transmitted Infections (STIs) trials